{"messages":[{"status":"ok","category":"all","interval":"2023-01-01:2023-01-31","cursor":0,"count":30,"count_new_papers":"749","total":"943"}], "collection":[{"title":"Excess Mortality and Years of Potential Life Lost Among Black People in the US from 1999 to 2020","authors":"Caraballo, C.; Massey, D.; Ndumele, C. D.; Haywood, T.; Kaleem, S.; King, T.; Liu, Y.; Lu, Y.; Nunez-Smith, M.; Taylor, H. A.; Watson, K. E.; Herrin, J.; Yancy, C. W.; Faust, J. S.; Krumholz, H. M.","author_corresponding":"Harlan M Krumholz","author_corresponding_institution":"Yale University","doi":"10.1101\/2022.11.12.22282253","date":"2023-01-02","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/02\/2022.11.12.22282253.source.xml","abstract":"ImportanceAmid efforts in the United States to promote health equity, there is a need to assess progress in reducing excess deaths and years of potential life lost (YPLL) among Black people compared with White people.\n\nObjectiveTo evaluate trends in excess mortality and YPLL among Black people compared with White people.\n\nDesignSerial cross-sectional.\n\nSettingNational data from the Centers for Disease Control and Prevention, 1999-2020\n\nParticipantsNon-Hispanic White and non-Hispanic Black people\n\nExposuresRace as documented in the death certificates.\n\nMain outcomes and measuresExcess age-adjusted all-cause and disease-specific mortality rate (per 100,000 individuals) and YPLL among Black people compared with White people.\n\nResultsFrom 1999 to 2020, the total number of excess deaths was 658,356 and 1,154,108 among Black females and males, representing 34,938,070 and 47,005,048 excess YPLL among Black females and males. The excess deaths and YPLL were largest among infants and non-elderly adults. Heart disease had the most excess deaths. From 1999, the age-adjusted excess mortality rate declined at an annual average of -9.0 (95% CI: -10.0, -8.0; P<0.001) until 2015 among Black women and at an annual average of -16.3 (95% CI: -20.9, -11.6; P<0.001) until 2012 among Black men, followed by no significant change until 2019 in either group. From 2019 to 2020, excess deaths increased from 90.4 to 192 per 100,000 Black women and from 209.8 to 395 per 100,000 Black men, reaching rates approximating those of 1999. The trends in rates of excess YPLL followed a similar pattern.\n\nConclusions and relevanceOver a recent 22-year period, Black people in the US lost more than 80 million years of life when compared with White people. After a period of progress, improvements stalled, and most gains were eliminated in 2020.\n\nKEY POINTSO_ST_ABSQuestionC_ST_ABSHow many excess deaths and years of potential life lost (YPLL) for Black people, compared with White people, occurred in the United States from 1999 through 2020?\n\nFindingsBased on Centers for Disease Control and Prevention data, excess deaths and YPLL persisted throughout the period, with initial progress followed by little improvement, and then worsening in 2020 to about 1999 levels. Black people had 1.8 million excess deaths and over 80 million YPLL over the study period.\n\nMeaningAfter initial progress, excess mortality and YPLL among Black people stagnated and then worsened, indicating a need for new approaches.","published":"NA","server":"medRxiv"},{"title":"Exploring the Efficacy and Feasibility of using Biomarkers for Early Screening of Lung Cancer and their Potential Reverberation on Mortality Rate: A Review","authors":"Safari Vejin, T.; O'Leary, J.; Singh, L.; Sullivan, T. J.","author_corresponding":"Tanaz Safari","author_corresponding_institution":"American University of Antigua College of Medicine","doi":"10.1101\/2022.12.30.22284074","date":"2023-01-02","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/02\/2022.12.30.22284074.source.xml","abstract":"IntroductionLung cancer patients often have a poor prognosis, due to various factors that play into the diagnosis, such as timeframe, early detection, and progression. The rate of patients with advanced-stage lung cancer is often high due to the inability to be diagnosed early. The lack of screening, therefore, increases the mortality rate of lung cancer. High mortality rate is also attributed to advanced lung cancer cases that are undiagnosed due to the lack of symptoms in patients early in disease acquisition.\n\nMethodsThis review explores lung cancer screening methods adopted around the world and those with the most promising standardizations. Criteria used to filter articles included lung cancer methods using biomarkers, research conducted in the United States within the past 10 years, screening methods observed in a clinical setting, and patients with primary lung cancer. Some practices that can be utilized to improve screening for lung cancer may involve using genetic markers to identify patients possessing genetic makeup associated with lung cancer.\n\nResultsOur study included 32 articles in our review calculating the sensitivity and specificity for a variety of potential biomarkers including: 1) Volatile organic compounds has a specificity of 80% and sensitivity of 80% 2) Circulating tumor DNA has a sensitivity of 80% and specificity of 96% 3) miRNA molecules (miR-146-5p, miR-324-5p, miR-223-3p, and miR-223-5p) displayed sensitivities of 93%, 94%, 96%, and 95% respectively, with specificities of 33%, 23%, 27%, and 26% respectively 4) methylation beads specific genomic sequences (SOX17, TAC1, HOXA7, CDO1, HOXA9, and ZFP42) with sensitivities of 84%, 86%, 63%, 78%, 93%, and 87% respectively when found in sputum and 73%, 76%, 34%, 65%, 86%, and 84% respectively when found in serum. Specificities were calculated at 88%, 75%, 92%, 67%, 8%, and 63% respectively when found in sputum, and 84%, 78%, 92%, 74%, 46%, and 54% respectively in serum 5) Ga-Alfatide II scans were found to have a sensitivity of 86% and a specificity of 85% 6) Combined score had a sensitivity of 78% and specificity of 50% 7) WT-IDH had a sensitivity of 63% and specificity of 93%.\n\nDiscussionIn such a high-risk patient population, cautious preventative measures can be used such as lifestyle choices and environmental exposures that are known risk factors. Informed physicians will be able to provide care directed toward minimizing patients modifiable risk factors to lower incidence rate and routine imaging offered when there is an index of suspicion to minimize mortality rate in high-risk populations. This review highlighted practices such as circulating tumor DNA and a Ga-Alfatide II CT\/PET scan that can be utilized to improve screening in the future and further dissected errors made in lung cancer diagnosis.","published":"NA","server":"medRxiv"},{"title":"Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation","authors":"Dekker, M. M.; Coffeng, L. E.; Pijpers, F. P.; Panja, D.; de Vlas, S. J.","author_corresponding":"Mark M. Dekker","author_corresponding_institution":"Department of Information and Computing Sciences, Utrecht University, Utrecht, The Netherlands","doi":"10.1101\/2022.03.31.22273222","date":"2023-01-02","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/02\/2022.03.31.22273222.source.xml","abstract":"To curb the initial spread of SARS-CoV-2, many countries relied on nation-wide implementation of non-pharmaceutical intervention measures, resulting in substantial socio-economic impacts. Potentially, subnational implementations might have had less of a societal impact, but comparable epidemiological impact. Here, using the first COVID-19 wave in the Netherlands as a case in point, we address this issue by developing a high-resolution analysis framework that uses a demographically-stratified population and a spatially-explicit, dynamic, individual contact-pattern based epidemiology, calibrated to hospital admissions data and mobility trends extracted from mobile phone signals and Google. We demonstrate how a subnational approach could achieve similar level of epidemiological control in terms of hospital admissions, while some parts of the country could stay open for a longer period. Our framework is exportable to other countries and settings, and may be used to develop policies on subnational approach as a better strategic choice for controlling future epidemics.","published":"10.7554\/eLife.80819","server":"medRxiv"},{"title":"Transitions across Kidney Disease Stages and Association with New-onset Heart Failure: a Population-Based study of 8569 Individuals and 12.6 Years of Follow-up","authors":"Chen, Y.; Bakker, S. J.; Suthahar, N.; Meems, L. M. G.; Groothof, D.; van Veldhuisen, D. J.; van Gilst, W. H.; de Boer, R. A.; Gansevoort, R. T.; Lunter, G.; Hillege, H. L.; Postmus, D.","author_corresponding":"Yuntao Chen","author_corresponding_institution":"Univeristy College London","doi":"10.1101\/2022.12.31.22284047","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284047.source.xml","abstract":"BackgroundLimited data exist on transitions across Kidney Disease Improving Global Outcomes (KDIGO) risk stages and association with new-onset heart failure (HF) in the general population.\n\nMethodsData were extacted from the first four clinical examinations of the PREVEND study. Participants were categorized into eGFR and albuminuria risk stages according to KDIGO Guideline. Multi-state model was fitted to estimate the transition rates across consecutive KDIGO risk stages and the association with new-onset HF.\n\nResults8569 participants were included at baseline. During a median follow-up of 12.6 years, 373 participants were diagnosed with new-onset HF and 710 participants had died before new-onset HF. The transition rate from low risk to intermediate risk stage did not differ between women and men; it increased from 0 to 10 transitions per 100 person-years from age 50 to 75 years. The transition rate from intermediate risk to high or very high risk stage increased exponentially with age, with women having lower rates (HR: 0.50, 95%CI: 0.34-0.76). Younger subjects and women were more likely to make a backward transition from intermediate risk to low risk stage. More advanced KDIGO risk stages were associated with increased risk of new-onset HF, and the risk association attenuates with age on the relative scale but strengthens with age on the absolute scale.\n\nConclusionsSlowing the progression of KDIGO risk stages may result in an important reduction in the incidence of new-onset heart failure in this population of middle-aged subjects.","published":"NA","server":"medRxiv"},{"title":"The illusion of personal health decisions for infectious disease management: disease spread in social contact networks","authors":"Michalska-Smith, M.; Enns, E.; White, L. A.; Gilbertson, M. L.; Craft, M. E.","author_corresponding":"Matthew Michalska-Smith","author_corresponding_institution":"University of Minnesota","doi":"10.1101\/2023.01.01.22284075","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2023.01.01.22284075.source.xml","abstract":"Close contacts between individuals provide opportunities for the transmission of diseases, including COVID-19. Individuals take part in many different types of interactions, including those with classmates, co-workers, and household members; the conglomeration of all of these interactions produces a complex social contact network interconnecting individuals across the population. Thus, while an individual might decide their own risk tolerance in response to a threat of infection, the consequences of such decisions are rarely so confined, propagating far beyond any one person. We asses the effect of different population-level risk-tolerance regimes, population structure in the form of age and household-size distributions, and different types of interactions on epidemic spread in plausible human contact networks to gain insight into how contact network structure affects pathogen spread through a population. In particular, we find that changes in behaviour of vulnerable individuals in isolation is insufficient to reduce those individuals infection risk, that population structure can have varied and counter-acting effects on epidemic outcomes, and that, in general, interactions among co-workers have a greater contribution to disease spread than do interactions among children at school. Taken together, these results promote a nuanced understanding of disease spread on contact networks, with implications for public health strategies.","published":"NA","server":"medRxiv"},{"title":"A Physiologically-Based Pharmacokinetic Model for Tuberculosis Drug Disposition at Extrapulmonary Sites","authors":"Ramachandran, A.; Gadgil, C.","author_corresponding":"Chetan Gadgil","author_corresponding_institution":"National Chemical Laboratory","doi":"10.1101\/2022.12.31.22284083","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"pharmacology and therapeutics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284083.source.xml","abstract":"Tuberculosis (TB) is a leading cause of mortality due to an infectious agent. TB primarily targets the lungs but in about 16% cases can affect other organs as well, giving rise to extrapulmonary TB (EPTB). However, an optimal regimen for EPTB treatment is not defined. While the recommended treatment for most forms of EPTB is the same as pulmonary TB, pharmacokinetics of EPTB therapy are not as well-studied. To address this gap, we formulate a whole-body physiologically-based pharmacokinetic (PBPK) model for EPTB that for the first time includes the ability to simulate drug concentrations in the pleura and lymph node. Using this model, we estimate the time-dependent concentrations, at potential EPTB infection sites, of the 4 first-line anti-TB drugs: Rifampicin, Ethambutol, Isoniazid and Pyrazinamide. We utilise reported plasma concentration kinetics data to estimate model parameters for each drug, and validate our model using reported concentration data not used for model formulation or parameter estimation. Model predictions match the validation data and reported PK parameters (Cmax, tmax) for the drugs. The model also predicts Ethambutol, Isoniazid and Pyrazinamide concentrations in the pleura that match reported experimental values from an independent study. For each drug, the model is used to simulate the time-dependent drug concentrations at various EPTB sites. Predicted drug concentrations are compared to their critical concentration. Simulations suggest that while Rifampicin and Isoniazid concentrations are greater than critical concentration values at most EPTB sites, the concentrations of Ethambutol and Pyrazinamide are lower than their critical concentrations at most EPTB sites.","published":"10.1002\/psp4.13008","server":"medRxiv"},{"title":"A stronger association of depression with rheumatoid arthritis in presence of obesity and hypertriglyceridemia","authors":"Shand, G.; Fuller, D. T.; Lufkin, L.; Lovelett, C.; Pal, N.; Mondal, S.; Sur, S.","author_corresponding":"Shantanu Sur","author_corresponding_institution":"Clarkson University","doi":"10.1101\/2023.01.01.23284106","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2023.01.01.23284106.source.xml","abstract":"BackgroundRheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic and systemic inflammation. Recent research underscores the role of chronic inflammation in multiple common RA comorbidities such as depression, obesity, and cardiovascular diseases (CVDs), suggesting a potential overlap of the pathogenic mechanisms for RA. However, it is not well understood how the coexistence of these comorbid conditions impacts the risk of RA and whether any such association relates to the inflammatory status of the body.\n\nMethodsWe used data from the 2007-2010 United States National Health and Nutrition Examination Survey (NHANES) database and compared RA prevalence between subsamples with the presence of any two conditions among depression, obesity, and hypertriglyceridemia (HTG). Each subsample was further divided into three categories based on the serum level of the inflammatory marker C-reactive protein (CRP) and analyzed for statistically significant differences using three-way {chi}2 tests of independence.\n\nResultsThe study was conducted on 4,136 patients who fulfilled the inclusion criteria (representing 163,540,241 individuals after adjustment for sampling weights). Rates of depression, obesity, and HTG were found to be significantly higher (P < 0.001) among the subjects with RA compared with the control population with no arthritis. The presence of depression along with obesity or HTG showed a noticeably higher RA prevalence but such an association was not observed for the combination of obesity and HTG. The synergistic effect of HTG with depression was found to be most prominent at a medium CRP level (1-3 mg\/L), while for obesity, the effect was observed across all CRP levels examined. These findings were further confirmed by the three-way {chi}2 test for independence.\n\nConclusionsThe presence of obesity or HTG in subjects suffering from depression might pose an increased risk of RA. Inflammatory mechanisms potentially play an important underlying role as suggested by the strong dependency of the association to CRP level. Identification of synergistic associations between RA risk conditions could provide useful information to predict the development and progress of RA.","published":"10.3389\/fepid.2023.1216497","server":"medRxiv"},{"title":"Nomogram for the Prediction of Shunt-Dependent Hydrocephalus in Patients with Aneurysmal Subarachnoid Hemorrhage: A Single-institute Experience","authors":"Wu, C.-R.; Chen, J.-S.; Chen, Y.-S.; Yin, C.-H.; Liao, W.-C.; Wu, Yu-Lun, W. Y.-L.; Hsu, Y.-H.","author_corresponding":"Yu-Hone Hsu","author_corresponding_institution":"Kaohsiung Veterans General Hospital, Neurosurgery","doi":"10.1101\/2022.12.31.22283967","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22283967.source.xml","abstract":"BACKGROUNDThis study is focused to identify the risk factors of shunt-dependent hydrocephalus (SDHC) after aneurysmal subarachnoid hemorrhage (aSAH) and develop a model to predict its incidence.\n\nMETHODSMedical records of 118 consecutive patients with aSAH treated in our institution from January 2013 to October 2021 were reviewed retrospectively, 109 of them were enrolled in this cohort, the following data were analyzed based on presence or absence of SDHC: age, gender, body mass index, Fisher grade, Hunt and Hess scale (HHS), aneurysm location, treatment modality, new neurological deficits after aneurysm treatment, estimated glomerular filtration rate (eGFR), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and platelet-neutrophil ratio (PNR). We conducted univariate and multivariate logistic regression analyses to illustrate a nomogram for predicting SDHC risk.\n\nRESULTSThe stepwise logistic regression analysis with backward selection revealed three independent predictive factors of SDHC: age [&ge;]65 (odds ratio, 3.94; 95% CI, 1.4-11.00; p = 0.009), treatment modality (odds ratio, 4.36; 95% CI, 1.81-10.53; p = 0.001), and HHS [&ge;]3 (odds ratio, 3.59; 95% CI, 1.50-8.61; p = 0.004). A nomogram for SDHC risk prediction was developed based on the weight of these 3 factors.\n\nCONCLUSIONSAge, treatment modality (clipping vs coiling), and HHS are predictive for SDHC after aSAH. Endovascular embolization of aneurysm plays an important role in reducing risk of SDHC after aSAH.","published":"NA","server":"medRxiv"},{"title":"Nomogram-based survival predictions of patients with soft tissue cancer including heart in the United States","authors":"Ahmmad, R.","author_corresponding":"Roungu Ahmmad","author_corresponding_institution":"University of Mississippi Medical Center, USA","doi":"10.1101\/2022.12.31.22284079","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284079.source.xml","abstract":"IntroductionThis study aimed to assess the effects of cancer treatment on sarcoma types and to predict overall survival probabilities using nomograms.\n\nMethodsThis study uses the SEER-18 database, Version 2020, sponsored by the National Cancer Institute (NCI). The study cohort included participants diagnosed between 2000 and 2018 with soft tissue cancers including heart. A multivariable Cox proportional hazards model was applied to predict mortality rate, and nomograms were used to predict overall survival probability.\n\nResultsThe median survival time for 24,849 study participants was 48 months (IQR: 19-102) with Spindle Cell Sarcoma (ScS) having a shorter median survival time compared with Liposarcoma (LiS). A significant number of STS patients had surgery, where surgery on ScS improved survival by 75% (HR: 0.25, 95%CI: 0.19-0.32, p<0.001) and those who received radiation had a 26% improvement (HR: 0.74, 95%CI: 0.61-0.89, p=0.001). Furthermore, chemotherapy on GcS resulted in a 40% reduction in mortality for patients compared to those who did not receive chemotherapy (HR 0.60, 95%CI:0.45-0.80, p<0.001). Based on nomogram, after two, five, and ten years, a patient who received surgery on their primary sites would have a survival rate of approximately 90 percent. In contrast, a patient who did not receive surgery on their primary sites would only live for 20 percent or less. Patients with MyS have a 90% chance of surviving for 5 and 10 years after surgery, but only 22% and 10% without surgery.\n\nConclusionsBased on the results of this study, surgical and radiation intervention on sarcomas was associated with improved survival in patients with STS, while chemotherapy and primary systemic therapy had contradictory effects.","published":"NA","server":"medRxiv"},{"title":"Interaction of mitochondrial polygenic score and environmental factors in LRRK2 p.Gly2019Ser parkinsonism","authors":"Lueth, T.; Gabbert, C.; Koenig, I. R.; Caliebe, A.; Koch, S.; Laabs, B.-H.; Hentati, F.; Sassi, S. B.; Amouri, R.; Spielmann, M.; Klein, C.; Gruenewald, A.; Farrer, M. J.; Trinh, J.","author_corresponding":"Joanne Trinh","author_corresponding_institution":"Institute of Neurogenetics, University of Luebeck, Luebeck, Germany","doi":"10.1101\/2023.01.02.23284113","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2023.01.02.23284113.source.xml","abstract":"The objective of our study was to investigate the impact of the mitochondrial polygenic score (MGS) and lifestyle\/environmental data on age at onset in LRRK2 p.Gly2019Ser parkinsonism (LRRK2-PD) and idiopathic Parkinsons disease (iPD).\n\nIn this study, we included N=486 patients with LRRK2-PD and N=9259 patients with iPD from AMP-PD, Fox Insight, and a Tunisian Arab-Berber founder population. Genotyping data was utilized to perform the MGS analysis, using 14 Single Nucleotide Polymorphisms (SNPs) from genes causally associated with mitochondrial function and PD risk. Additionally, lifestyle and environmental data were obtained from the PD risk factor questionnaire (PD-RFQ). Correlation analyses and linear regression models were used to assess the relationship between MGS, lifestyle\/environment, and AAO.\n\nWe observed that higher MGS was associated with earlier AAO in patients with LRRK2-PD (p=4.0x10-4, {beta}=-0.18) but not in patients with iPD. A correlation between MGS and AAO was visibly stronger in European ancestry LRRK2-PD patients (p=0.01, r=-0.16) than in Tunisian Arab-Berber patients (p=0.44, r=-0.05). We found that the MGS interacted with coffee (p=0.03, {beta}=-0.38) and caffeinated soda consumption (p=0.03, {beta}=-0.37) in LRRK2-PD and with caffeine soda consumption (p=0.047, {beta}=-0.22) and pesticide exposure (p=0.02, {beta}=-0.37) in iPD. Thus, patients with a high MGS had an earlier AAO only if they consumed caffeine or were exposed to pesticides.\n\nThe MGS related to mitochondrial function was associated with AAO in LRRK2-PD but not iPD with an ethnic-specific effect. Caffeine consumption or pesticide exposure interacted with MGS to predict PD AAO. Our study suggests gene-environment interactions as modifiers of AAO in LRRK2-PD.","published":"NA","server":"medRxiv"},{"title":"Multi-Criteria Ambulance Location Problem: better to treat some fast, or more in time?","authors":"Muench, J.; Leithaeuser, N.; Moos, M.; Werner, J.; Scherer, G.","author_corresponding":"Johanna Muench","author_corresponding_institution":"Fraunhofer Institute for Industrial Mathematics ITWM","doi":"10.1101\/2023.01.02.23284112","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2023.01.02.23284112.source.xml","abstract":"For the location optimization of several ambulance stations, we outline a multi-criteria integer program to maximize the reached population within different time bounds. This technique is based on a realistic driving time estimation for ambulances on a detailed road network. The results show that, depending on which time bound is more valued, ambulance stations are more likely to be located in urban areas or evenly distributed across the study region. We used this model for real-world studies in Southwest Germany, where several ambulance station locations were optimized simultaneously.","published":"NA","server":"medRxiv"},{"title":"Prognostic nutrition index, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio combined detection, superior to single detection correlates with prognosis of patients with chronic hepatitis C-associated cirrhosis complicated by T2DM","authors":"WU, D.; wang, x.; ding, y.; zhu, y.; liu, y.; li, t.; gao, y.; wang, x. j.","author_corresponding":"xiao juan wang","author_corresponding_institution":"Fuyang People\\'s Hospital","doi":"10.1101\/2022.12.30.22284073","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.30.22284073.source.xml","abstract":"BackgroundPrognostic nutrition index (PNI), Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) have been studied widely in cancer diseases. However, their correlation with chronic hepatitis C-associated cirrhosis complicated by T2DM mellitus is unknown.\n\nAimTo investigate the correlation of PNI, NLR and PLR with chronic hepatitis C-associated cirrhosis complicated by T2DM.They were associated with the prognosis of patients.\n\nMethodsWe investigated 226 patients. Of the patients, 56 cases were with chronic hepatitis C-associated cirrhosis complicated by T2DM mellitus patients (group A), 85 cases were with chronic hepatitis C-associated cirrhosis patients (group B), and 85 cases were with T2DM patients (group C). According to the prognosis of chronic hepatitis C-associated cirrhosis complicated by T2DM after 6 months of treatment, patients were divided into poor prognosis (23 cases) and good prognosis (33 cases). The baseline data and of all patients were analyzed. All data were collected from the database of the hospital patient electronic medical record system.\n\nResultsA comparison of baseline data among the three groups showed significant differences in age (P value=0.008). The levels of PNI were obvious difference in three groups (P value < 0.01). The level of NLR in the group A was significantly lower than in the group C. The level of NLR in the group B was significantly lower than in the group C and the group A. The level of PNI in the group A was significantly lower than in the group C. The level of PNI in the group A was significantly lower than in the group B. The level of PLR in the group A was significantly lower than in the group C. The level of PLR in the group B was significantly higher than in the group C. NLR, PNI, PLR were significantly different in the good prognosis group and the poor prognosis group (P value < 0.05). We calculated AUC for combined determination of PNI, NLR and PLR, and it showed excellent diagnostic performance (AUC = 0.911,95% CI 0.741-0.985, Sensitivity = 80.00 %, and Specificity = 88.89%).\n\nConclusionsPNI, NLR and PLR were closely related to the prognosis of chronic hepatitis C-associated cirrhosis complicated by T2DM, and their combined detection had the highest specificity and sensitivity for early prediction of the poor prognosis of chronic hepatitis C-associated cirrhosis complicated by T2DM, which had important clinical value.","published":"NA","server":"medRxiv"},{"title":"Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients","authors":"Dewald, F.; Prikl, M.; Ahmadov, E.; Paluschinski, M.; Kuehn, J.; Elsner, C.; Schulte, B.; Schlotz, M.; Oral, G.; Knuefer, J.; Bernhard, M.; Michael, M.; Luxenburger, M.; Andree, M.; Hennies, M. T.; Hafezi, W.; Mueller, M. M.; Kuempers, P.; Risse, J.; Kill, C.; Manegold, R. K.; von Frantzki, U.; Schulte, B.; Richter, E.; Monzon Posadas, W.; Graeff, I.; Kogej, M.; Buening, A.; Baum, M.; Teipel, F.; Mochtarzadeh, B.; Wolff, M.; Gruell, H.; Di Cristanziano, V.; Burst, V.; Streeck, H.; Dittmer, U.; Ludwig, S.; Timm, J.; Klein, F.","author_corresponding":"Florian Klein","author_corresponding_institution":"University of Cologne","doi":"10.1101\/2022.12.31.22284088","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284088.source.xml","abstract":"Determining SARS-CoV-2 immunity is critical to assess COVID-19 risk and the need for prevention and mitigation strategies. We measured SARS-CoV-2 Spike\/Nucleocapsid seroprevalence and serum neutralizing activity against Wu01, BA.4\/5 and BQ.1.1 in 1,411 individuals who received medical treatment in five emergency departments in North Rhine-Westphalia, Germany. We detected Spike-IgG in 95.6%, Nucleocapsid-IgG in 24.0% and neutralization against Wu01, BA.4\/5 and BQ.1.1 in 94.4%, 85.0%, and 73.8% of participants, respectively. Neutralization against BA.4\/5 and BQ.1.1 was reduced 5.6- and 23.4-fold compared to Wu01. Accuracy of S-IgG detection for determination of neutralizing activity against BQ.1.1 was reduced substantially. Furthermore, we explored previous vaccinations and infections as most important correlates of improved BQ.1.1 neutralization using multivariable and Bayesian network analyses. Given an adherence to COVID-19 vaccination recommendations of only 67.7% of all participants, we highlight the need for improvement of vaccine-uptake to reduce the COVID-19 risk in upcoming infection-waves with immune evasive variants.","published":"NA","server":"medRxiv"},{"title":"Usability and performance of the MicroGEM Sal6830, an RT-PCR saliva-based point-of-care platform to detect SARS-CoV-2 in primary healthcare settings with non-laboratory trained operators.","authors":"Mills, V.; Owen Tyson, T.; Helton, R.; Hill-Collins, P.; Hubbard, S.; Scott, A.; Hickey, J.; Root, B. E.; O'Brien, R.; Conte, J.; Stanton, J.-A. L.; Chapman, J. D.","author_corresponding":"Jo-Ann L Stanton","author_corresponding_institution":"MicroGEM, Charlottesville, Virginia, United States of America","doi":"10.1101\/2023.01.01.22283267","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2023.01.01.22283267.source.xml","abstract":"The beginning of the COVID-19 pandemic demonstrated how few point-of-care diagnostic tools were available that could be safely and easily operated by healthcare workers with no laboratory training. The gold-standard test, and initially the only test, used RT-PCR with nasal pharyngeal swabs (NPS). Two issues quickly emerged: 1) RT-PCR required central laboratory processing leading to significant time delays and 2) NPS collection causes discomfort, is inappropriate for ongoing repeat sampling of individuals (e.g., frontline healthcare workers) and poses difficulty when obtaining samples from some sections of the population (e.g. some elderly and young children). The Sal6830 platform is a fully self-contained, RT-PCR point-of-care device for detecting SARS-CoV-2 from saliva that takes less than thirty minutes to complete. In this study we tested the usability of the Sal6830 platform by healthcare workers unfamiliar with the instrument at two community clinics: Care 4 U Community Health Center (Miami, Florida, USA) and St. Marys Health Wagon (Wise, Virginia, USA). Staff participated in three tests: 1) determining SARS-CoV-2 status from blinded positive and negative saliva samples, 2) a clinical study comparing SARS-CoV-2 detection with a comparator point-of-care technology from the same patient and 3) completing a survey designed to measure comfort and confidence using the Sal6830 point-of-care device having received no training. Participants overwhelming found the Sal6830 platform easy and intuitive to use, successfully called SARS-CoV-2 status of contrived, blinded samples and measured a 93.3% overall percent agreement when comparing patient samples across two point-of-care technologies.","published":"NA","server":"medRxiv"},{"title":"iCVS - Inferring Cardio-Vascular hidden States from physiological signals available at the bedside","authors":"Ravid Tannenbaum, N.; Gottesman, O.; Assadi, A.; Mazwi, M.; Shalit, U.; Eytan, D.","author_corresponding":"Danny Eytan","author_corresponding_institution":"Technion Israel Institute of Technology","doi":"10.1101\/2022.12.31.22284089","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"intensive care and critical care medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284089.source.xml","abstract":"Intensive care medicine is complex and resource-demanding. A critical and common challenge lies in inferring the underlying physiological state of a patient from partially observed data. Specifically for the cardiovascular system, clinicians use observables such as heart rate, arterial and venous blood pressures, as well as findings from the physical examination and ancillary tests to formulate a mental model and estimate hidden variables such as cardiac output, vascular resistance, filling pressures and volumes, and autonomic tone. Then, they use this mental model to derive the causes for instability and choose appropriate interventions. Not only this is a very hard problem due to the nature of the signals, but it also requires expertise and a clinicians ongoing presence at the bedside. Clinical decision support tools based on mechanistic dynamical models offer an appealing solution due to their inherent explainability, corollaries to the clinical mental process, and predictive power. With a translational motivation in mind, we developed iCVS: a simple, with high explanatory power, dynamical mechanistic model to infer hidden cardiovascular states. Full model estimation requires no prior assumptions on physiological parameters except age and weight, and the only inputs are arterial and venous pressure waveforms. iCVS also considers autonomic and non-autonomic modulations. To gain more information without increasing model complexity, both slow and fast timescales of the blood pressure traces are exploited, while the main inference and dynamic evolution are at the longer, clinically relevant, timescale of minutes. iCVS is designed to allow bedside deployment at pediatric and adult intensive care units and for retrospective investigation of cardiovascular mechanisms underlying instability. In this paper, we describe iCVS and inference system in detail, and using a dataset of critically-ill children, we demonstrate its use and power to identify bleeding, distributive states, and cardiac dysfunction, in isolation and in combination.\n\nAuthor summaryA common challenge clinicians face across different disciplines is estimating the hidden physiological state of a patient based on partially observed data. Here we describe iCVS (inferring Cardio-Vascular States): a dynamical mechanistic model of the cardiovascular system. We developed iCVS with a translational goal in mind, showing high explanatory power, its inference relies only on routinely available signals, and enables the identification of various clinically important shock states. We demonstrate the use of the model on a dataset that was collected in a pediatric intensive care unit.","published":"NA","server":"medRxiv"},{"title":"Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study","authors":"Song, R.; Zeng, G.; Yu, J.; Meng, X.; Chen, X.; Li, J.; Xie, X.; Lian, X.; Zhang, Z.; Cao, Y.; Yin, W.; Jin, R.","author_corresponding":"Ronghua Jin","author_corresponding_institution":"Beijing Ditan Hospital, Capital Medical University","doi":"10.1101\/2022.12.28.22283666","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.28.22283666.source.xml","abstract":"BACKGROUNDThis study has assessed a new Anti-COVID-19 Monoclonal Antibody Nasal Spray (SA58) for post-exposure prophylaxis (PEP) against symptomatic coronavirus disease 2019 (COVID-19).\n\nMETHODSWe conducted an efficacy study in adults aged 18 years and older within three days of exposure to a SARS-CoV-2 infected individual. Recruited participants were randomized in a ratio of 3:1 to receive SA58 or placebo. Primary endpoints were laboratory-confirmed symptomatic COVID-19 within study period.\n\nFINDINGSA total of 1,222 participants were randomized and dosed (SA58, n=901; placebo, n=321). Median of follow-up was 2{middle dot}25 days and 2{middle dot}79 days for SA58 and placebo, respectively. Adverse events occurred in 221 of 901 (25%) and 72 of 321 (22%) participants with SA58 and placebo, respectively, with no significant difference (P=0{middle dot}49). All adverse events were mild in severity. Laboratory-confirmed symptomatic COVID-19 developed in 7 of 824 participants (0{middle dot}22 per 100 person-days) in the SA58 group vs 14 of 299 (1{middle dot}17 per 100 person-days) in the placebo group, resulting in an estimated efficacy of 80 {middle dot} 82% (95%CI 52 {middle dot} 41%-92 {middle dot} 27%). There were 32 SARS-CoV-2 RT-PCR positives (1{middle dot}04 per 100 person-days) in the SA58 group vs 32 (2{middle dot}80 per 100 person-days) in the placebo group, resulting in an estimated efficacy of 61{middle dot}83% (95%CI 37{middle dot} 50%-76{middle dot} 69%). A total of 21 RT-PCR positive samples were sequenced. 21 lineages of SARS-CoV-2 variants were identified, and all were the Omicron variant BF{middle dot}7.\n\nINTERPRETATIONSA58 Nasal Spray showed favorable efficacy and safety in preventing SARS-CoV-2 infection or symptomatic COVID-19 in healthy adult workers who had exposure to SARS-CoV-2 within 72 hours.\n\nFUNDINGNo funding was received for this study.\n\nResearch in contextO_ST_ABSEvidence before this studyC_ST_ABSMonoclonal antibodies (mAbs) and the post-exposure prophylaxis (PEP) with mAbs represent a very important public health strategy against COVID-19 outbreak. SA58 Nasal Spray is a broad-spectrum anti-COVID-19 mAb, developed by Sinovac Life Sciences Ltd. for treatment and prophylaxis against COVID-19. SA58 has been shown to potently neutralize ACE2-utilizing sarbecoviruses, including most of circulating Omicron variants. We searched PubMed on Nov 21, 2022, for published clinical trials, with no language or date restrictions, using various combinations of the search terms of \"monoclonal antibodies\", \"SARS-CoV-2\", \"COVID-19\", \"prophylaxis\", and \"prevention\". Three published trials were identified. The first study reported the efficacy of AZD7442 (tixagevimab\/cilgavimab) PEP against symptomatic COVID-19 in adults aged [&ge;]18 years over a 183-day follow-up period. The primary efficacy end point of post-exposure prevention of symptomatic COVID-19 was not met, though AZD7442 showed promising results in participants who were SARS-CoV-2 RT-PCR negative at baseline. The second study reported the efficacy and safety of bamlanivimab for COVID-19 prevention in household contacts of individuals with a SARS-CoV-2 infection in a high-risk transmission setting over a one-month efficacy assessment period. The third study reported REGEN-COV (casirivimab\/imdevimab) for preventing symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection in previously uninfected household contacts of infected persons. Both bamlanivimab and REGEN-COV showed satisfactory safety profile and efficacy against COVID-19 and were licensed for PEP use in the U.S. However, due to the circulating Omicron variants have developed significant escape properties, the emergency use authorization of bamlanivimab and REGEN-COV for treatment and PEP against COVID-19 has been discontinued by the U.S. Food and Drug Administration. Till the end of December 2022, no drug was available for PEP use against COVID-19.\n\nAdded value of this studyDuring a recent large outbreak of the Omicron BF{middle dot}7 sublineage in Beijing, our preliminary results in healthy adults within 72 hours of contact with SARS-CoV-2-infected individuals showed that SA58 nasal spray was highly effective in preventing symptomatic COVID-19 and SARS-CoV-2 infection caused by the sublineage, which variants have shown significant escape of immunity in previous studies. SA58 was able to significantly lower the risk of laboratory-confirmed COVID-19 by 80{middle dot}82% (95%CI 52{middle dot}41%-92{middle dot}27%) and of SARS-CoV-2 infection by 61{middle dot}83% (95%CI 37{middle dot}50%-76{middle dot}69%) in our study participants.\n\nImplications of all the available evidenceThis trial showed the ability of a nasal spray of broad-spectrum anti-COVID-19 mAb SA58 to provide satisfactory protection against one circulating Omicron strain of SARS-CoV-2. The drug had a favorable safety profile and was well tolerated by healthy adults. This newly developed mAb is resistant to SARS-CoV-2 mutations and may provide a new powerful countermeasure to tackle against the immunity-escaping variants of SARS-CoV-2 circulating in the population. The intranasal administration of SA58 is novel and has many advantages over intramuscular injections of mAbs previously licensed, as it is less invasive and more acceptable in recipients. Auto-administration with easiness of use may allow early administration, probably a key feature for prevention.","published":"NA","server":"medRxiv"},{"title":"Immunogenicity and safety of Biological Es CORBEVAX vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD or COVAXIN: A Prospective double-blind randomised phase III clinical study","authors":"Thuluva, S.; Paradkar, V.; Gunneri, S.; Yerroju, V.; Mogulla, R. R.; Venkata Suneetha, P.; Turaga, K.; Binayke, A.; Zaheer, A.; Awasti, A.; Virkar, R.; Narang, M.; Nanjappa, P.; Mahantshetti, N.; Garg, B.; Mandal, R.","author_corresponding":"Subhash Thuluva","author_corresponding_institution":"Biological E. Limited","doi":"10.1101\/2022.12.29.22284049","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.29.22284049.source.xml","abstract":"BackgroundVaccines developed against Covid-19 infection were effective in controlling symptomatic infections and hospitalizations. However, waning immunity was reported within 6 months of primary vaccination series. Due to waning of SARS-CoV-2 specific primary immunity, protection towards emerging variants of concern (VoC) was low. To rejuvenate the immunogenicity of vaccines, a third or booster dose was highly recommended by many state governments. In this regard, several clinical studies were conducted to evaluate the homologous or heterologous booster dose effectiveness against VoCs and showed that heterologous immune boosting more effective in controlling breakthrough infections. In this study, we studied the safety and immunogenicity of Biological-Es CORBEVAX vaccine in adult population as a heterologous booster dose.\n\nMethodsThis is a prospective phase-3, randomised, double-blind, placebo-controlled, study evaluating safety, reactogenicity, tolerability and immunogenicity of CORBEVAX vaccine as a heterologous booster dose administered to adult volunteers previously vaccinated with two doses of either COVISHIELD or COVAXIN at least 6 months ago. Subjects were RT-PCR negative to SARS-CoV-2 prior to enrolment. A total of 416 subjects between 18 to 80 years of age, were enrolled in to one of the two treatment (COVISHIELD or COVAXIN primed subjects) groups (n=208\/group) for safety and immunogenicity assessment. Within each group (n=208), subjects were randomized to receive CORBEVAX vaccine or placebo in a 3:1 ratio.\n\nFindingsThe safety profile of CORBEVAX vaccine administered as booster dose is comparable to the placebo-control group. All the reported adverse events (AEs) were mild to moderate in their intensity. There was no grade 3 or serious or AEs of special interest (AESI) reported during the study period and all the reported AEs resolved without any sequelae. CORBEVAX booster dose administration resulted in significant increase in humoral immune response (nAb titers and Anti-RBD IgG concentration) that was much superior to the placebo in both COVISHIELD and COVAXIN recipient arms. Significant increase in nAb titers against Omicron VOC as well as cellular immune response was also observed post CORBEVAX booster dose administration.\n\nInterpretationsEnhancement of immune response coupled with excellent safety profile of the CORBEVAX booster dose demonstrates significant benefit of giving CORBEVAX heterologous booster dose to subjects that have received COVISHIELD or COVAXIN primary vaccination; as early as 6 months post second dose of primary vaccination.\n\nThe study was prospectively registered with clinical trial registry of India-CTRI\/2022\/01\/039366","published":"10.1016\/j.ijregi.2025.100786","server":"medRxiv"},{"title":"Cannabis and Microbiome: A Systematic Review and Meta-Analysis.","authors":"Thu, M. S.; Ondee, T.; Hall, S. R.; Nopsopon, T.; Jagota, A.; Hirankarn, N.; Pongpirul, K.","author_corresponding":"Krit Pongpirul","author_corresponding_institution":"Chulalongkorn University Faculty of Medicine","doi":"10.1101\/2022.12.31.22284080","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"addiction medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284080.source.xml","abstract":"BackgroundWith cannabis legalization spreading to more countries for both medicinal and recreational use, grasping its effects on the human body is vital. The endocannabinoid system, governed by natural and external cannabinoid compounds, significantly impacts host metabolism. Working alongside the hosts immunomodulation, it shapes the gut microbiota, yielding benefits for the GI and immune systems.\n\nObjectiveTo assess the link between cannabis treatment and the gut\/oral microbiome.\n\nMethodsWe extensively searched PubMed, Embase, and Cochrane Librarys CENTRAL until December 9, 2023, for English studies involving adults with clinical abnormalities. Identified studies were analyzed, categorizing by different clinical aspects. Data was then qualitatively and quantitatively synthesized.\n\nResultThe study involved 10 studies encompassing 2511 participants, comprising 2 clinical trials and 8 observational studies. The review provided a range of microbiota by the influence of cannabis usage within different clinical contexts: HIV infection, pain\/inflammation, systemic aspergillosis, obesity, cognitive deficits, and oral diseases. Users with anhedonia and HIV infection showed lower -diversity, but those with knee arthritis showed higher -diversity. According to research, 21.4% of MJ cigarette users experienced adverse outcomes; however, these lessened once they stopped smoking.\n\nConclusionThese findings shed light on the complex effects of cannabis use on the human microbiota, underscoring the need for future research on the therapeutic potential of cannabis. This review provides valuable insights to guide future investigations in this field.\n\nRegistration IDPROSPERO 2022 CRD42022354331\n\nShort SummaryWith the global expansion of cannabis legalization, understanding the effects of cannabis on the human body, particularly among individuals with diverse clinical conditions, is of paramount importance. Through a meticulous systematic review utilizing comprehensive data, our findings uncover that cannabis consumption in adults with varied clinical conditions leads to discernable alterations in the human microbiome. These noteworthy modifications necessitate careful consideration in future investigations exploring the potential beneficial or adverse effects of cannabis treatment on patients.","published":"NA","server":"medRxiv"},{"title":"Post-Coronary Artery Bypass Graft Complications; Potential Causes and Risk Factors","authors":"Marzoog, B. A.; Karpunkin, O. A.; Tremasov, M. N.; Kostin, S. V.","author_corresponding":"Basheer Abdullah Marzoog","author_corresponding_institution":"National research Ogarev Mordovia State university","doi":"10.1101\/2022.12.29.22284005","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"cardiovascular medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.29.22284005.source.xml","abstract":"BackgroundCardiovascular disease (CVD) remains the leading cause of death worldwide despite the coexistence of the current COVID-19 pandemic. Current emergency management involves revascularization of the coronary arteries.\n\nAimsRetrospectively evaluating the association between the used number of shunts and postoperative complications. And to evaluate the potential pre\/postoperative risk factors for complications development.\n\nObjectivesSeveral complications are reported after coronary artery bypass graft (CABG) surgery, such as postoperative arrythmia and postoperative stroke. However, the risk factors for the development remain not elaborated.\n\nMaterial and methodsA retrospective cohort study involved 290 patients for the period 2017-2021 treated surgically for ischemic heart disease. The surgery includes shunts of the internal thoracic arteries with the post-occlusion coronary arteries. The number of shunts is varied depending on the size and number of occluded arteries. According to the number of shunts, the patient may be operated with artificial circulation (CPB; cardiopulmonary bypass), or without working heart (OFF pump; without artificial circulation. For statistical analysis, used T test, one way ANOVA test, and Pearson correlation test by using Statistica program.\n\nResultsThe most frequently reported complication is postoperative hydrothorax, 28 (11.20%) patients. Patients with CABG and left ventricle aneurysm plastic surgery repair had a longer aortic cross-clamp time, t-value -2.20413, p <0.028306. Furthermore, patients with CABG have less ejection fraction, t-value 5.10667, p < 0.000001. Patients with post-CABG left ventricle (LV) aneurysm had less ejection fraction, t-value -2.01070, p <0.045292. Furthermore, patients with post-CABG LV aneurysm had a longer CPB time, t value -5.58113, p < 0.000000. Patients with post-CABG LV aneurysm had a longer aortic cross-clamp time, t-value -4.72802, p < 0.000004. Patients with postoperative hydrothorax are with low BMI and longer CPB and Aortic cross-clamp time, t-value -2.33929, p <0.020021; t-value 3.83233, P < 0.000157; t-value 2.71109, p < 0.007119, respectively. Subsequently, post-operative hydrothorax increases the intensive care unit (ICU) and total hospitalization days, t-value 5.80811, p < 0.000000; t-value 7.37431, p < 0.000000, respectively. Patients who have preoperative progressive angina have higher number of complications, t-value 2.108504, p < 0.035866. Post myocardial infarction myocardial sclerosis patients (PMIMS) have a higher number of complications, t-value 2.516784, p < 0.012396. No statistical correlation between number of the complications and the number of the shunts. Furthermore, there was no statistical association between the used number of internal thoracic arteries and the number of complications. A direct correlation between number of complications and age\/CPB time\/ aortic cross-clamp time\/ICU hospitalization days\/total hospitalization days, r= 0.138565, 0.204061, 0.162078, 0.487048, 0.408381; respectively.\n\nConclusionsPostoperative complication rate associated with the pre-existence of progressive angina and PMIMS. Elderly people undergoing CABG are at higher risk of psychosis, arrythmia, longer total and ICU hospitalization days, and stroke. Advanced age, longed CPB time, prolonged Aortic cross-clamp time, long ICU hospitalization days, and long total hospitalization days are risks for more frequent post CABG complications.\n\nOthersThe number of complications is not associated with the death and alive status of the patients or with the number of shunts.","published":"10.2174\/0250688204666230410084313","server":"medRxiv"},{"title":"Developing a Deep Learning Ultrasonography Model to Classify Thyroid Nodules as Benign","authors":"Peddakama, R.","author_corresponding":"Rishi Peddakama","author_corresponding_institution":"Del Norte High School","doi":"10.1101\/2022.12.31.22284087","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc0_ng","category":"radiology and imaging","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284087.source.xml","abstract":"1.<Introduction>Thyroid cancer, or the occurrence of rapid cell growth in the thyroid gland located near the neck, is the fastest growing cancer among women. Papillary thyroid cancer leads to hormonal imbalances thus causing periods of fatigue, difficulty breathing, and an overall decrease in ones quality of life.\n\n<Objective>Unsurprisingly, the need for a quick diagnosis of thyroid cancer has become ever more important. Deep learning is a subset of machine learning that may improve the diagnostic performance of ultrasound, including in the evaluation of thyroid nodules (irregular growths that develop on the gland) for benign vs. malignant disease. Currently, the standard method to differentiate benign or malignant thyroid nodules is an invasive test known as Fine Needle Aspirations (FNAs) that is uncomfortable and may lead to unwanted outcomes such as bleeding, and infection.\n\n<Methods>We propose using a convolutional neural network with a foundation rooted in two pre-trained networks, VGG-16 and InceptionV3, to train a model on the publicly available Thyroid Digital Image Database to accurately classify thyroid nodules on ultrasonography into those that are malignant or benign; a non-invasive strategy.\n\n<Results>The data was augmented using industry-standard methods and provisioned into train\/test\/validation sets obtaining 88% accuracy and an area under the receiver operating characteristic (ROC) of 0.929 (signifying a high sensitivity).\n\n<Discussion>Based on the models results, it is conceived that a convolutional neural network can serve as an accurate classifier of malignant\/benign thyroid nodules from an ultrasound and enhance a diagnostic strategy to reduce unnecessary FNA procedures.","published":"NA","server":"medRxiv"},{"title":"Risk Factors for Traumatic Brain Injury in Men and Women","authors":"Marzoog, B. A.","author_corresponding":"Basheer Abdullah Marzoog","author_corresponding_institution":"National research Ogarev Mordovia State university","doi":"10.1101\/2022.12.29.22284004","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"neurology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.29.22284004.source.xml","abstract":"ObjectivesThe study covers the current status of TBI and provides a statistical recommendation to health organizations in the world.\n\nDesignA retrospective analytical study. The descriptive results showed that a difference exists between males and females and for these reasons the sample was divided into two groups according to the primary descriptive statistics. The first group included 212 (31.59 %) females, while the second group included 459 (68.40%) males.\n\nSettingAssess the risk factors for TBI in both sexes and compare them with the results of international studies.\n\nParticipantsThe study involved 671 patients for the period from 07\/01\/2017-17\/12\/2018. The primary data were collected from the republic hospital.\n\nInterventionsRetrospectively analysed these patients using T test, one- and two-way ANOVA test, and the Pearson correlation test using the Statistica 12 program. The study divided into male and female by using the ROC and AUC values.\n\nMain Outcome MeasuresThe most frequently reported cause of TBI in men and women is domestic accidents. Men are affected by TBI in early life compared to women.\n\nResultsThe mean age of the men is 44.41 years (Std. error 0.75). The mean age of the women is 49.50 years (Std. error 1.38). In the male group, 354 (77.12 %) patients live in the city and 105 (22.87%) live in the village. However, in the female group, 170 (80.18%) patients live in the city and 42 (19.81%) live in the village. In the men group, 172 (37.47%) patients had TBI due to domestic accidents. The most frequently reported etiology of TBI in women is domestic accident, reported in 122 (57.54 %). In female group, the mean age of patients with domestic accident associated TBI is 53.76 years (Std. error 1.85). In male group, the mean age of patients with domestic accident associated TBI is 50.74 years (Std. error 1.09). Total hospitalization days of the patients were associated with the age of the patients, r= 0.12. Where men are hospitalized longer than women, t value -2.261, p < 0.024. In the male and female groups, there is a direct correlation between age and the total hospitalization days in the male group, r=0.173; r=0.148, respectively.\n\nConclusionThe most frequently reported cause of TBI in men and women is domestic accidents. Men are affected by TBI in early life compared to women.","published":"NA","server":"medRxiv"},{"title":"Evaluation of Simple and Convenient Methods for SARS-CoV-2 Detection in Wastewater in high and Low Resource Settings","authors":"Liu, P.; Guo, L.; Cavallo, M.; Cantrell, C.; Hilton, S. P.; Dunbar, J.; Barbero, R.; Barclay, R.; Sablon, O.; Wolfe, M. K.; Lepene, B.; Moe, C. L.","author_corresponding":"Pengbo Liu","author_corresponding_institution":"Emory University","doi":"10.1101\/2022.12.31.22284093","date":"2023-01-03","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.31.22284093.source.xml","abstract":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA monitoring in wastewater has become an important tool for COVID-19 surveillance. Although many viral concentration methods such as membrane filtration and skim milk are reported, these methods generally require large volumes of wastewater, expensive lab equipment, and laborious processes. We utilized a Nanotrap(R) Microbiome A Particles (Nanotrap particle) method for virus concentration in wastewater. The method was evaluated across six parameters: pH, temperature, incubation time, wastewater volumes, RNA extraction methods, and two virus concentration approaches vs. a one-step method. The method was further evaluated with the addition of the Nanotrap Enhancement Reagent 1 (ER1) by comparing the automated vs. a manual Nanotrap particle method. RT-qPCR targeting the nucleocapsid protein was used for detection and quantification of SARS-CoV-2 RNA. Different pH, temperature, incubation time, wastewater volumes, and RNA extraction methods did not result in reduced SARS-CoV-2 detection in wastewater samples. The two-step concentration method showed significantly better results (P<0.01) than the one-step method. Adding ER1 to wastewater prior to viral concentration using the Nanotrap particles significantly improved PCR Ct results (P<0.0001) in 10 mL grab samples processed by automated Nanotrap particle method or 10 mL and 40 mL samples processed by manual Nanotrap particle method. SARS-CoV-2 detection in 10 mL grab samples with ER1 and the automated method showed significantly better (P=0.0008) results than 150 mL grab samples using the membrane filtration method. SARS-CoV-2 detection in 10 mL swab samples with ER1 via the automated method was also significantly better than without ER1 (P<0.0001) and the skim milk method in 250 mL Moore swab samples (P=0.012). These results suggest that Nanotrap methods could substitute the traditional membrane filtration and skim milk methods for viral concentration without compromising on the assay sensitivity. The manual method can be used in resource-limited areas, and the high-throughput platform is appropriate for large-scale COVID-19 wastewater-based surveillance.","published":"NA","server":"medRxiv"},{"title":"Promoting Activity, Independence and Stability in early dementia and mild cognitive impairment (PrAISED): A randomised controlled trial","authors":"Harwood, R. H.; Goldberg, S. E.; Brand, A.; van der Wardt, V.; Booth, V.; Di Lorito, C.; Hoare, Z.; Hancox, J.; Bajwa, R.; Burgon, C.; Howe, L.; Cowley, A.; Bramley, T.; Long, A.; Lock, J.; Tucker, R.; Adams, E.; O'Brien, R.; Kearney, F.; Kowalewska, K.; Godfrey, M.; Dunlop, M.; Junaid, K.; Thacker, S.; Duff, C.; Welsh, T.; Haddon-Silver, A.; Gladman, J.; Logan, P.; Pollock, K.; Vedhara, K.; Hood, V.; Das Nair, R.; Smith, H.; Edwards, R. T.; Hartfiel, N.; Ezeofor, V.; Vickers, R.; Orrell, M.; Masud, T.","author_corresponding":"Rowan H Harwood","author_corresponding_institution":"University of Nottingham","doi":"10.1101\/2022.12.20.22283699","date":"2023-01-03","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"geriatric medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/03\/2022.12.20.22283699.source.xml","abstract":"BackgroundDementia is associated with frailty leading to increased risks of falls and hospitalisations. Interventions are required to maintain functional ability, strength and balance.\n\nDesignMulti-centre parallel group randomised controlled trial, with embedded process evaluation. Procedures were adapted during the COVID-19 pandemic.\n\nParticipantsPeople with mild dementia or mild cognitive impairment (MCI), living at home, and a family member or carer.\n\nObjectivesTo determine the effectiveness of an exercise and functional activity therapy intervention compared to usual care.\n\nInterventionA specially-designed dementia-specific rehabilitation programme focussing on strength, balance, physical activity and performance of ADL, which was tailored, progressive, addressed risk and the psychological and learning needs of people with dementia, providing up to 50 therapy sessions over 12 months. The control group received usual care plus a falls risk assessment.\n\nMain outcome measureThe primary outcome was the informant-reported Disability Assessment for Dementia (DAD) 12 months after randomisation. Secondary outcomes were: self-reported ADL, cognition, physical activity, quality of life, frailty, balance, functional mobility, fear of falling, mood, carer strain and service use (at 12 months) and falls (between months 4 and 15).\n\nResults365 people were randomised, 183 to intervention and 182 to control. Median age of participants was 80 years (range 65-95), median Montreal Cognitive Assessment score 20\/30 (range 13-26), 58% were men. Participants received a median of 31 (IQR = 22-40) therapy sessions out of a possible maximum of 50. Participants reported completing a mean 121 minutes\/week of PrAISED activity outside of supervised sessions. Primary outcome data were available for 149 (intervention) and 141 (control) participants. There was no difference in DAD scores between groups: adjusted mean difference -1.3\/100, 95% Confidence Interval (-5.2 to +2.6); Cohens d effect size -0.06 (-0.26 to +0.15); p=0.5. Upper 95% confidence intervals excluded small to moderate effects on any of the range of secondary outcome measures. Between months 4 and 15 there were 79 falls in the intervention group and 200 falls in the control group, adjusted incidence rate ratio 0.78 (0.5 to 1.3); p= 0.3.\n\nConclusionThe intensive PrAISED programme of exercise and functional activity training did not improve ADLs, physical activity, quality of life, reduce falls or improve any other secondary health status outcomes even though uptake was good. Future research should consider alternative approaches to risk reduction and ability maintenance.\n\nTrial registrationISRCTN15320670.\n\nFundingNational Institute for Health and Care Research\n\nWhat is already knownO_LIDementia is associated with progressive loss of functional ability, including activities of daily living and mobility, and a high risk of falls\nC_LIO_LIExercise programmes and rehabilitation therapies may improve ability, or slow the rate of decline, but evidence from trials and systematic reviews is equivocal\nC_LI\n\nWhat this study tells usO_LIWe developed an intensive dementia-specific exercise and functional activity rehabilitation programme, lasting 12 months, taking account of motivation, learning needs and context, in particular the need to engage carers, and evaluated it in a randomised controlled trial\nC_LIO_LIThe programme was very well received by participants and therapists, but had no effect on activities of daily living, physical activity, quality of life, falls, cognition or any other health status outcome\nC_LIO_LIWe are unlikely to be able to change rate of loss of ability in dementia through exercise or functionally orientated rehabilitation therapy.\nC_LIO_LIWe need different ways of defining wellbeing after a dementia diagnosis.\nC_LI","published":"NA","server":"medRxiv"},{"title":"Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1","authors":"Tsui, L. H.; Lambert, B.; Bajaj, S.; McCrone, J. T.; Inward, R. P. D.; Bosetti, P.; Hill, V.; Pena, R. E.; Zarebski, A. E.; Peacock, T. P.; Liu, L.; Wu, N.; Davis, M.; Bogoch, I. I.; Khan, K.; Colquhoun, R.; O'Toole, A.; Jackson, B.; Dasgupta, A.; Wilkinson, E.; Tegally, H.; de Oliveira, T.; The COVID-19 Genomics UK (COG-UK) consortium,  ; Connor, T. R.; Loman, N. J.; Colizza, V.; Fraser, C.; Volz, E.; Ji, X.; Suchard, M. A.; Gutierrez, B.; Chand, M.; Dellicour, S.; Cauchemez, S.; Raghwani, J.; Lemey, P.; Rambaut, A.; Pybus, O. G.; Kraemer, M. U. G.","author_corresponding":"Lok Hei Tsui","author_corresponding_institution":"University of Oxford","doi":"10.1101\/2023.01.02.23284109","date":"2023-01-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2023.01.02.23284109.source.xml","abstract":"SARS-CoV-2 variants of concern (VOCs) arise against the backdrop of increasingly heterogeneous human connectivity and population immunity. Through a large-scale phylodynamic analysis of 115,622 Omicron genomes, we identified >6,000 independent introductions of the antigenically distinct virus into England and reconstructed the dispersal history of resulting local transmission. Travel restrictions on southern Africa did not reduce BA.1 importation intensity as secondary hubs became major exporters. We explored potential drivers of BA.1 spread across England and discovered an early period during which viral lineage movements mainly occurred between larger cities, followed by a multi-focal spatial expansion shaped by shorter distance mobility patterns. We also found evidence that disease incidence impacted human commuting behaviours around major travel hubs. Our results offer a detailed characterisation of processes that drive the invasion of an emerging VOC across multiple spatial scales and provide unique insights on the interplay between disease spread and human mobility.\n\nHighlightsO_LIOver 6,000 introductions ignited the epidemic wave of Omicron BA.1 in England\nC_LIO_LIImportations prior to international travel restrictions were responsible for majority of local BA.1 infections but importations continued from sources other than southern Africa\nC_LIO_LIHuman mobility at regional and local spatial scales shaped dissemination and growth of BA.1\nC_LIO_LIChanges in human commuting patterns are associated with higher case incidence in travel hubs across England\nC_LI","published":"10.1126\/science.adg6605","server":"medRxiv"},{"title":"Development of a Suicide Prevention Life Gatekeeper Training Program in China: A Delphi study","authors":"Cai, C.; Yin, C.; Tong, Y.; Qu, D.; Ding, Y.; Ren, D.; Chen, P.; Yin, Y.; An, J.; Chen, R.","author_corresponding":"Runsen Chen","author_corresponding_institution":"Vanke School of Public Health, Tsinghua University, Beijing, China","doi":"10.1101\/2023.01.01.22284096","date":"2023-01-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2023.01.01.22284096.source.xml","abstract":"IntroductionYouth suicide has been a pressing public mental health concern in China, yet there is a lack of localised gatekeeper intervention programs developed for Chinese schools. Life Gatekeeper was the first systematically developed gatekeeper program which aimed to equip teachers and parents with knowledge, skills, and ability to identify and intervene students at high risk of suicide. This study aimed to achieve expert consensus on the content of this program.\n\nMethodsThe Delphi method was used to elicit consensus on statements essential to include in the training program. In the form of scoring existing statements and responding to open-ended questions, experts have the opportunity to evaluate the content, delivery form, feasibility, and overall feeling of the initial training program. Two Delphi rounds were conducted among Chinese panel members with diversified professional backgrounds in suicide research and practice. Statements were accepted for inclusion in the adjusted training program if they were endorsed by at least 80% of the panel.\n\nResultsConsensus was achieved on 201 statements out of 207 statements for inclusion in the adapted guidelines for the gatekeeper programme, with 151 from the original questionnaire, and 50 generated from the comments of the panel members. These endorsed statements were used to develop the Life Gatekeeper training program.\n\nConclusionThis Delphi study provided an evidence base in developing of the first gatekeeper training program in China. We hope that the current study could pave the way for more evidence based suicide prevention programs in China. Further study is warranted to evaluate the effectiveness of the Life Gatekeeper training program.","published":"NA","server":"medRxiv"},{"title":"Awareness of Cervical Cancer and Screening in Benin and Cameroon:  Analysis of the Demographic and Health Survey (DHS)","authors":"Olajide, N.; Jani, B. D.; Niedzwiedz, C. L.; Johnman, C.; Robb, K. A.","author_corresponding":"Nike Olajide","author_corresponding_institution":"University of Glasgow School of Health and Wellbeing","doi":"10.1101\/2023.01.03.23284133","date":"2023-01-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2023.01.03.23284133.source.xml","abstract":"Cervical cancer incidence and mortality are high in Africa. We assessed cervical cancer and screening awareness in two West African countries.\n\nWe used data from the Demographic and Health Survey (DHS) in Benin (DHS 2017-2018) and Cameroon (DHS 2018). Women (n=21322) aged 15-49 were interviewed on awareness of cervical cancer and cervical cancer screening. Descriptive statistics and logistic regression analysis were used.\n\nAwareness of cervical cancer was low among women in Cameroon (46.1%) and very low in Benin (9.5%). Among those aware of cervical cancer, 51.4% in Benin and 59.7% in Cameroon were also aware of cervical screening. In the adjusted analysis, women in Cameroon aged 45+ had the highest awareness odds of both cervical cancer (adjusted odds ratio-aOR 2.91, [2.36-3.60]) and screening (aOR 1.75, [1.33-2.29]). In Benin, women aged 45+ had the highest cervical cancer awareness (aOR 1.89 [1.23-2.91]) while screening awareness was highest in women aged 25-34 years (aOR 1.98, [1.20-3.27]). Women with higher education were six to nine times more aware of cervical cancer and three to four times more aware of cervical screening than women with no education in Benin and Cameroon respectively. Additionally, cervical cancer awareness was approximately four times higher in the richest wealth quintile in Cameroon. In Benin, the odds of awareness of cervical cancer were increased with daily internet use (aOR 3.61, [2.45-5.32]) and radio listening once a week (aOR 1.73 [1.04-2.88]) compared to no internet and no radio listening respectively. In Cameroon, both awareness of cervical cancer and screening increased with daily internet use (aOR 1.95 [1.61-2.35]) and (aOR 1.35 [1.10-1.67]) respectively.\n\nThere is a need to increase awareness of cervical cancer and screening in Benin and Cameroon and likely among other West African countries. The internet and radio appear to be important potentially effective means for raising awareness.","published":"NA","server":"medRxiv"},{"title":"Students' perspectives on global surgery and its integration into formal medical education","authors":"Rennie, N.; Degraeuwe, E.; Deltour, C.; Serry Senhaji, M.; Vandenheede, M.; Berrevoet, F.; Van Daele, E.; Willaert, W.","author_corresponding":"Nicholas Rennie","author_corresponding_institution":"Ghent University Faculty of Medicine and Health Sciences: Universiteit Gent Faculteit Geneeskunde en Gezondheidswetenschappen","doi":"10.1101\/2023.01.03.23284155","date":"2023-01-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"medical education","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2023.01.03.23284155.source.xml","abstract":"Global surgery is \"an area of study, research, practice, and advocacy that seeks to improve health outcomes and achieve health equity for all people who require surgical care\". The Lancet Commission on Global Surgery strives for an additional 2.28 million physicians in the global surgery workforce by 2030. Understanding how medical students perceive global surgery will be essential in educating the next generation of global surgeons, anaesthesiologists and obstetricians. This study investigated the knowledge, attitudes and exposure of Belgian medical students towards global surgery.\n\nAn anonymous online survey was distributed to first to final year medical students across Belgian universities using social media. Data was collected on demographics, exposure, knowledge, obstacles and attitudes of medical students towards global surgery. Odds ratios with 95% confidence intervals were calculated.\n\nA total of 304 medical students participated from four Belgian universities. A minority of students reported having exposure to global surgery (24.7%). Most students were interested in gaining more exposure to global surgery (75.3%). Almost all students agreed (94.4%) that global surgery is a relevant topic for medical students, and most agreed (71%) that there should be more compulsory education on the topic. Only 13 to 44% of students could correctly answer questions testing global surgery knowledge. Students reported multiple barriers to pursuing a career in global surgery. Belgian medical students global surgery knowledge and exposure is lacking despite clear interest in the field. Educating and supporting students will be essential in supporting them to take on careers in global surgery. These results advocate for the inclusion of pre-clinical global surgery seminars alongside equitable international clinical internships in formal medical education across Europe and worldwide.","published":"NA","server":"medRxiv"},{"title":"Efficacy and Mechanisms of Cannabis Oil for Alleviating Side Effects of Breast Cancer Chemotherapy (CBC2): Protocol for Randomized Controlled Trial.","authors":"Thu, M. S.; Pongpirul, K.; Vongsaisuwon, M.; Vinayanuwattikun, C.; Banchuen, K.; Ondee, T.; Payungporn, S.; Phutrakool, P.; Nootim, P.; Chariyavilaskul, P.; Cherdchom, S.; Wanaratna, K.; Hirankarn, N.","author_corresponding":"Krit Pongpirul","author_corresponding_institution":"Chulalongkorn University Faculty of Medicine","doi":"10.1101\/2023.01.01.23284097","date":"2023-01-04","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2023.01.01.23284097.source.xml","abstract":"BackgroundIn a pilot study using both cannabidiol (CBD) and tetrahydrocannabinol (THC) as single agents in advanced cancer patients undergoing palliative care in Thailand, the doses were generally well tolerated, and the outcome measure of total symptom distress scores showed overall symptom benefit. The current study aims to determine the intensity of the symptoms experienced by breast cancer patients receiving chemotherapy, to explore the microbiome profile, cytokines, and bacterial metabolites before and after the treatment with cannabis oil or no cannabis oil, and to study the pharmacokinetics parameters and pharmacogenetics profile of the doses.\n\nMethodsA randomized, double-blinded, placebo-controlled trial will be conducted on the metastatic breast cancer cases receiving chemotherapy at King Chulalongkorn Memorial Hospital (KCMH), Bangkok, Thailand. Block randomization will be used to allocate the patients into three groups: Ganja Oil (THC 2 mg\/ml; THC 0.08 mg\/drop, and CBD 0.02 mg\/drop), Metta Osot (THC 81 mg\/ml; THC 3 mg\/drop), and placebo oil. The Edmonton Symptom Assessment System (ESAS), microbiome profile, cytokines, and bacterial metabolites will be assessed before and after the interventions.\n\nThai Clinical Trial RegistrationTCTR20220809001","published":"10.1186\/s12906-024-04426-0","server":"medRxiv"},{"title":"Profiling of circulating glial cells allows accurate blood-based diagnosis of glial malignancies","authors":"O'Neill, K.; Syed, N.; Crook, T.; Dubey, S.; Potharaju, M.; Limaye, S.; Ranade, A.; Anichini, G.; Patil, D.; Murthy, S. S.; Akolkar, D.; Fulmali, P.; Bendale, K.; Datta, V.; Schuster, S.; Patel, S.; Patil, S.; Chougule, R.; Apurwa, S.; Shejwalkar, P.; John, J.; Srinivasan, A.; Datar, R.","author_corresponding":"Nelofer Syed","author_corresponding_institution":"Department of Brain Sciences, John Fulcher Neuro-Oncology Laboratory, Burlington Danes Building, Hammersmith  Hospital, Imperial College London, London, UK","doi":"10.1101\/2022.07.06.22277300","date":"2023-01-04","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2022.07.06.22277300.source.xml","abstract":"We describe an in vitro test for detection of glial malignancies (GLI-M) based on enrichment and immunostaining of Circulating Glial Cells (CGCs) from peripheral blood sample. Extensive analytical validation studies using U87MG reference cell lines spiked into blood established the analytical performance characteristics of the test. The ability of the test to detect and differentiate GLI-M from non-malignant brain tumors (NBT), non glial type central nervous system (CNS) malignancies (NGCM), brain metastases from primary epithelial malignancies in other organs and healthy individuals were evaluated in four studies. The cumulative performance metrics of the test across all 4 clinical studies were 99.35% Sensitivity (95%CI: 96.44% - 99.98%) and 100% Specificity (95%CI: 99.37% - 100%). The performance characteristics of this test support its clinical utility for diagnostic triaging of individuals presenting with ICSOL.","published":"10.1002\/ijc.34827","server":"medRxiv"},{"title":"Multivariate variance components analysis uncovers genetic architecture of brain isoform expression and novel psychiatric disease mechanisms","authors":"Kim, M.; Vo, D.; Jops, C.; Wen, C.; Patowary, A.; Bhattacharya, A.; Yap, C.; Zhou, H.; Gandal, M.","author_corresponding":"Minsoo Kim","author_corresponding_institution":"David Geffen School of Medicine, UCLA","doi":"10.1101\/2022.10.18.22281204","date":"2023-01-04","version":"2","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2023\/01\/04\/2022.10.18.22281204.source.xml","abstract":"Multivariate variance components linear mixed models are fundamental statistical models in quantitative genetics, widely used to quantify SNP-based heritability (h2SNP) and genetic correlation (rg) across complex traits. However, maximum likelihood estimation of multivariate variance components models remains numerically challenging when the number of traits and variance components are both greater than two. To address this critical gap, here we introduce a novel statistical method for fitting multivariate variance components models. This method improves on existing methods by allowing for arbitrary number of traits and\/or variance components. We illustrate the utility of our method by characterizing for the first time the genetic architecture of isoform expression in the human brain, modeling up to 23 isoforms jointly across [~]900 individuals within PsychENCODE. We find a significant proportion of isoforms to be under genetic control (17,721 of 93,293 isoforms) with substantial shared genetic effects among local (or cis-) relative to distal (or trans-) genetic variants (median rg,cis and rg,trans = 0.31 and 0.06). Importantly, we find that 11.6% of brain-expressed genes (2,900 genes) are heritable only at the isoform-level. Integrating these isoform-specific genetic signals with psychiatric GWAS signals uncovers previously hidden psychiatric disease mechanisms. Specifically, we highlight reduced expression of a specific XRN2 isoform as the underlying driver of the strongest GWAS signal for autism spectrum disorder. Overall, our method for fitting multivariate variance components models is flexible, widely applicable, and is implemented in the Julia programming language and available online.","published":"NA","server":"medRxiv"}]}